82 related articles for article (PubMed ID: 27009385)
1. Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells.
Tiago DM; Conceição N; Caiado H; Laizé V; Cancela ML
FEBS Lett; 2016 Apr; 590(8):1234-41. PubMed ID: 27009385
[TBL] [Abstract][Full Text] [Related]
2. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract][Full Text] [Related]
3. MGP is downregulated due to promoter methylation in chemoresistant ER+ breast cancer and high MGP expression predicts better survival outcomes.
Tuo YL; Ye YF
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3871-3878. PubMed ID: 28975977
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of MGP gene expression in colorectal cancer.
Caiado H; Conceição N; Tiago D; Marreiros A; Vicente S; Enriquez JL; Vaz AM; Antunes A; Guerreiro H; Caldeira P; Cancela ML
Gene; 2020 Jan; 723():144120. PubMed ID: 31589964
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling.
Cario-Toumaniantz C; Boularan C; Schurgers LJ; Heymann MF; Le Cunff M; Léger J; Loirand G; Pacaud P
J Vasc Res; 2007; 44(6):444-59. PubMed ID: 17643059
[TBL] [Abstract][Full Text] [Related]
6. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
[TBL] [Abstract][Full Text] [Related]
7. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
8. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
10. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.
Zhang H; Fan Q
Oncol Rep; 2015 Oct; 34(4):2163-70. PubMed ID: 26239614
[TBL] [Abstract][Full Text] [Related]
13. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
[TBL] [Abstract][Full Text] [Related]
15. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance.
Huynh FC; Jones FE
PLoS One; 2014; 9(12):e114419. PubMed ID: 25532106
[TBL] [Abstract][Full Text] [Related]
17. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
Schwickert A; Weghake E; Brüggemann K; Engbers A; Brinkmann BF; Kemper B; Seggewiß J; Stock C; Ebnet K; Kiesel L; Riethmüller C; Götte M
PLoS One; 2015; 10(12):e0143993. PubMed ID: 26657485
[TBL] [Abstract][Full Text] [Related]
18. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
Lin L; Liu D; Liang H; Xue L; Su C; Liu M
Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer.
Ding W; Fan XL; Xu X; Huang JZ; Xu SH; Geng Q; Li R; Chen D; Yan GR
PLoS One; 2015; 10(8):e0135128. PubMed ID: 26258411
[TBL] [Abstract][Full Text] [Related]
20. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
